IQVIA Hldgs

IQVIA HOLDINGS INC

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

IQVIA Holdings

Analyst Color

Long Ideas

Health Care

Analyst Ratings

Tech

Trading Ideas

General

ILMN

NVDA

Scopriamo come l&#39;intelligenza artificiale stia rivoluzionando il settore sanitario, con analisi delle opportunità e delle potenziali sfide.

Intelligenza artificiale nella sanità: è la prossima scommessa di Nvidia

IQVIA Holdings Inc

Small Cap

Press Releases

AI Healthcare Funding Surges as Real-World Rollouts Hit Pharmacies, Hospitals, and Providers

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

Opinion

Healthcare's $110B AI Surge Is Picking Up Speed--and It's Just the Beginning

IQVIA Reports Second-Quarter 2025 Results

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

IQVIA Announces CFO Transition in Early 2026

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

AVAI

FHTX

GEHC

MRNA

RDNT

SANA

SOUN

VEEV

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

IQVIA Hldgs

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO